Table of Contents 1 Market Overview 1.1 Axial Spondyloarthritis Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Overview: Global Axial Spondyloarthritis Drugs Revenue by Type: 2015 VS 2019 VS 2025 1.2.2 Certolizumab Pegol 1.2.3 Etanercept Biosimilar 1.2.4 Ixekizumab 1.2.5 Secukinumab 1.2.6 Others 1.3 Market Analysis by Application 1.3.1 Overview: Global Axial Spondyloarthritis Drugs Revenue by Application: 2015 VS 2019 VS 2025 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Home Care 1.4 Overview of Global Axial Spondyloarthritis Drugs Market 1.4.1 Global Axial Spondyloarthritis Drugs Market Status and Outlook (2015-2025) 1.4.2 North America (United States, Canada and Mexico) 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy) 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.5 South America, Middle East & Africa 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 AstraZeneca Plc 2.1.1 AstraZeneca Plc Details 2.1.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis 2.1.3 AstraZeneca Plc SWOT Analysis 2.1.4 AstraZeneca Plc Product and Services 2.1.5 AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.2 UCB SA 2.2.1 UCB SA Details 2.2.2 UCB SA Major Business and Total Revenue (Financial Highlights) Analysis 2.2.3 UCB SA SWOT Analysis 2.2.4 UCB SA Product and Services 2.2.5 UCB SA Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.3 Novartis AG 2.3.1 Novartis AG Details 2.3.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis 2.3.3 Novartis AG SWOT Analysis 2.3.4 Novartis AG Product and Services 2.3.5 Novartis AG Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.4 Eli Lilly and Company 2.4.1 Eli Lilly and Company Details 2.4.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis 2.4.3 Eli Lilly and Company SWOT Analysis 2.4.4 Eli Lilly and Company Product and Services 2.4.5 Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.5 Sun Pharma Advanced Research Company Ltd 2.5.1 Sun Pharma Advanced Research Company Ltd Details 2.5.2 Sun Pharma Advanced Research Company Ltd Major Business and Total Revenue (Financial Highlights) Analysis 2.5.3 Sun Pharma Advanced Research Company Ltd SWOT Analysis 2.5.4 Sun Pharma Advanced Research Company Ltd Product and Services 2.5.5 Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.6 Johnson & Johnson 2.6.1 Johnson & Johnson Details 2.6.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis 2.6.3 Johnson & Johnson SWOT Analysis 2.6.4 Johnson & Johnson Product and Services 2.6.5 Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.7 Sandoz International GmbH 2.7.1 Sandoz International GmbH Details 2.7.2 Sandoz International GmbH Major Business and Total Revenue (Financial Highlights) Analysis 2.7.3 Sandoz International GmbH SWOT Analysis 2.7.4 Sandoz International GmbH Product and Services 2.7.5 Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 2.8 Panacea Biotec Ltd 2.8.1 Panacea Biotec Ltd Details 2.8.2 Panacea Biotec Ltd Major Business and Total Revenue (Financial Highlights) Analysis 2.8.3 Panacea Biotec Ltd SWOT Analysis 2.8.4 Panacea Biotec Ltd Product and Services 2.8.5 Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) 3 Sales, Revenue and Market Share by Manufacturer 3.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Manufacturer (2018-2019) 3.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Manufacturer (2018-2019) 3.3 Market Concentration Rate 3.3.1 Top 3 Axial Spondyloarthritis Drugs Manufacturer Market Share in 2019 3.3.2 Top 6 Axial Spondyloarthritis Drugs Manufacturer Market Share in 2019 3.4 Market Competition Trend 4 Global Market Analysis by Regions 4.1 Global Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Regions (2015-2020) 4.1.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Regions (2015-2020) 4.2 North America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 4.3 Europe Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 4.5 South America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 4.6 Middle East and Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 5 North America by Country 5.1 North America Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country 5.1.1 North America Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020) 5.1.2 North America Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020) 5.2 United States Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 5.3 Canada Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 5.4 Mexico Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 6 Europe by Country 6.1 Europe Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country 6.1.1 Europe Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020) 6.1.2 Europe Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020) 6.2 Germany Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 6.3 UK Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 6.4 France Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 6.5 Russia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 6.6 Italy Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 7 Asia-Pacific by Regions 7.1 Asia-Pacific Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Regions 7.1.1 Asia-Pacific Axial Spondyloarthritis Drugs Sales and Market Share by Regions (2015-2020) 7.1.2 Asia-Pacific Axial Spondyloarthritis Drugs Revenue and Market Share by Regions (2015-2020) 7.2 China Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 7.3 Japan Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 7.4 Korea Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 7.5 India Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 7.6 Southeast Asia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 7.7 Australia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 8 South America by Country 8.1 South America Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country 8.1.1 South America Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020) 8.1.2 South America Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020) 8.2 Brazil Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 8.3 Argentina Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 9 Middle East & Africa by Countries 9.1 Middle East & Africa Axial Spondyloarthritis Drugs Sales, Revenue and Market Share by Country 9.1.1 Middle East & Africa Axial Spondyloarthritis Drugs Sales and Market Share by Country (2015-2020) 9.1.2 Middle East & Africa Axial Spondyloarthritis Drugs Revenue and Market Share by Country (2015-2020) 9.2 Saudi Arabia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 9.3 Turkey Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 9.4 Egypt Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 9.5 South Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) 10 Market Segment by Type 10.1 Global Axial Spondyloarthritis Drugs Sales and Market Share by Type (2015-2020) 10.2 Global Axial Spondyloarthritis Drugs Revenue and Market Share by Type (2015-2020) 10.3 Global Axial Spondyloarthritis Drugs Price by Type (2015-2020) 11 Global Axial Spondyloarthritis Drugs Market Segment by Application 11.1 Global Axial Spondyloarthritis Drugs Sales Market Share by Application (2015-2020) 11.2 Global Axial Spondyloarthritis Drugs Revenue Market Share by Application (2015-2020) 11.3 Global Axial Spondyloarthritis Drugs Price by Application (2015-2020) 12 Market Forecast 12.1 Global Axial Spondyloarthritis Drugs Sales, Revenue and Growth Rate (2021-2025) 12.2 Axial Spondyloarthritis Drugs Market Forecast by Regions (2021-2025) 12.2.1 North America Axial Spondyloarthritis Drugs Market Forecast (2021-2025) 12.2.2 Europe Axial Spondyloarthritis Drugs Market Forecast (2021-2025) 12.2.3 Asia-Pacific Axial Spondyloarthritis Drugs Market Forecast (2021-2025) 12.2.4 South America Axial Spondyloarthritis Drugs Market Forecast (2021-2025) 12.2.5 Middle East & Africa Axial Spondyloarthritis Drugs Market Forecast (2021-2025) 12.3 Axial Spondyloarthritis Drugs Market Forecast by Type (2021-2025) 12.3.1 Global Axial Spondyloarthritis Drugs Sales Forecast by Type (2021-2025) 12.3.2 Global Axial Spondyloarthritis Drugs Market Share Forecast by Type (2021-2025) 12.4 Axial Spondyloarthritis Drugs Market Forecast by Application (2021-2025) 12.4.1 Global Axial Spondyloarthritis Drugs Sales Forecast by Application (2021-2025) 12.4.2 Global Axial Spondyloarthritis Drugs Market Share Forecast by Application (2021-2025) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source 15.3 Disclaimer 15.4 About US

List of Tables Table 1. Global Axial Spondyloarthritis Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025 Table 2. Breakdown of Axial Spondyloarthritis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Table 3. Global Axial Spondyloarthritis Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025 Table 4. Market Opportunities in Next Few Years Table 5. Market Risks Analysis Table 6. Market Drivers Table 7. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors Table 8. AstraZeneca Plc Axial Spondyloarthritis Drugs Major Business Table 9. AstraZeneca Plc Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 10. AstraZeneca Plc SWOT Analysis Table 11. AstraZeneca Plc Axial Spondyloarthritis Drugs Product and Services Table 12. AstraZeneca Plc Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 13. UCB SA Basic Information, Manufacturing Base and Competitors Table 14. UCB SA Axial Spondyloarthritis Drugs Major Business Table 15. UCB SA Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 16. UCB SA SWOT Analysis Table 17. UCB SA Axial Spondyloarthritis Drugs Product and Services Table 18. UCB SA Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 19. Novartis AG Basic Information, Manufacturing Base and Competitors Table 20. Novartis AG Axial Spondyloarthritis Drugs Major Business Table 21. Novartis AG Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 22. Novartis AG SWOT Analysis Table 23. Novartis AG Axial Spondyloarthritis Drugs Product and Services Table 24. Novartis AG Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 25. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors Table 26. Eli Lilly and Company Axial Spondyloarthritis Drugs Major Business Table 27. Eli Lilly and Company Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 28. Eli Lilly and Company SWOT Analysis Table 29. Eli Lilly and Company Axial Spondyloarthritis Drugs Product and Services Table 30. Eli Lilly and Company Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 31. Sun Pharma Advanced Research Company Ltd Basic Information, Manufacturing Base and Competitors Table 32. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Major Business Table 33. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 34. Sun Pharma Advanced Research Company Ltd SWOT Analysis Table 35. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Product and Services Table 36. Sun Pharma Advanced Research Company Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 37. Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table 38. Johnson & Johnson Axial Spondyloarthritis Drugs Major Business Table 39. Johnson & Johnson Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 40. Johnson & Johnson SWOT Analysis Table 41. Johnson & Johnson Axial Spondyloarthritis Drugs Product and Services Table 42. Johnson & Johnson Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 43. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors Table 44. Sandoz International GmbH Axial Spondyloarthritis Drugs Major Business Table 45. Sandoz International GmbH Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 46. Sandoz International GmbH SWOT Analysis Table 47. Sandoz International GmbH Axial Spondyloarthritis Drugs Product and Services Table 48. Sandoz International GmbH Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 49. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors Table 50. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Major Business Table 51. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Total Revenue (USD Million) (2017-2018) Table 52. Panacea Biotec Ltd SWOT Analysis Table 53. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Product and Services Table 54. Panacea Biotec Ltd Axial Spondyloarthritis Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019) Table 55. Global Axial Spondyloarthritis Drugs Sales by Manufacturer (2018-2019) (K Pcs) Table 56. Global Axial Spondyloarthritis Drugs Revenue by Manufacturer (2018-2019) (USD Million) Table 57. Global Axial Spondyloarthritis Drugs Sales by Regions (2015-2020) (K Pcs) Table 58. Global Axial Spondyloarthritis Drugs Sales Market Share by Regions (2015-2020) Table 59. Global Axial Spondyloarthritis Drugs Revenue by Regions (2015-2020) (USD Million) Table 60. North America Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs) Table 61. North America Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020) Table 62. North America Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million) Table 63. North America Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020) Table 64. Europe Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs) Table 65. Europe Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020) Table 66. Europe Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million) Table 67. Asia-Pacific Axial Spondyloarthritis Drugs Sales by Regions (2015-2020) (K Pcs) Table 68. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share by Regions (2015-2020) Table 69. Asia-Pacific Axial Spondyloarthritis Drugs Revenue by Regions (2015-2020) (USD Million) Table 70. South America Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs) Table 71. South America Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020) Table 72. South America Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million) Table 73. South America Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020) Table 74. Middle East & Africa Axial Spondyloarthritis Drugs Sales by Countries (2015-2020) (K Pcs) Table 75. Middle East & Africa Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020) Table 76. Middle East & Africa Axial Spondyloarthritis Drugs Revenue by Countries (2015-2020) (USD Million) Table 77. Middle East & Africa Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020) Table 78. Global Axial Spondyloarthritis Drugs Sales by Type (2015-2020) (K Pcs) Table 79. Global Axial Spondyloarthritis Drugs Sales Share by Type (2015-2020) Table 80. Global Axial Spondyloarthritis Drugs Revenue by Type (2015-2020) (USD Million) Table 81. Global Axial Spondyloarthritis Drugs Revenue Share by Type (2015-2020) Table 82. Global Axial Spondyloarthritis Drugs Sales by Application (2015-2020) (K Pcs) Table 83. Global Axial Spondyloarthritis Drugs Sales Share by Application (2015-2020) Table 84. Global Axial Spondyloarthritis Drugs Sales Forecast by Regions (2021-2025) (K Pcs) Table 85. Global Axial Spondyloarthritis Drugs Market Share Forecast by Regions (2021-2025) Table 86. Global Axial Spondyloarthritis Drugs Sales Forecast by Type (2021-2025) (K Pcs) Table 87. Global Axial Spondyloarthritis Drugs Market Share Forecast by Type (2021-2025) Table 88. Global Axial Spondyloarthritis Drugs Sales Forecast by Application (2021-2025) Table 89. Global Axial Spondyloarthritis Drugs Market Share Forecast by Application (2021-2025) Table 90. Direct Channel Pros & Cons Table 91. Indirect Channel Pros & Cons Table 92. Distributors/Traders/ Dealers List List of Figures Figure 1. Axial Spondyloarthritis Drugs Picture Figure 2. Global Sales Market Share of Axial Spondyloarthritis Drugs by Type in 2019 Figure 3. Certolizumab Pegol Picture Figure 4. Etanercept Biosimilar Picture Figure 5. Ixekizumab Picture Figure 6. Secukinumab Picture Figure 7. Others Picture Figure 8. Axial Spondyloarthritis Drugs Sales Market Share by Application in 2018 Figure 9. Clinic Picture Figure 10. Hospital Picture Figure 11. Home Care Picture Figure 12. Global Axial Spondyloarthritis Drugs Market Status and Outlook (2015-2025) (USD Million) Figure 13. United States Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 14. Canada Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 15. Mexico Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 16. Germany Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 17. France Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 18. UK Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 19. Russia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 20. Italy Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 21. China Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 22. Japan Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 23. Korea Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 24. India Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 25. Southeast Asia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 26. Australia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million) Figure 27. Brazil Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 28. Egypt Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 29. Saudi Arabia Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 30. South Africa Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 31. Turkey Axial Spondyloarthritis Drugs Revenue (Value) and Growth Rate (2015-2025) Figure 32. Global Axial Spondyloarthritis Drugs Sales Market Share by Manufacturer in 2019 Figure 33. Global Axial Spondyloarthritis Drugs Revenue Market Share by Manufacturer in 2019 Figure 34. Top 3 Axial Spondyloarthritis Drugs Manufacturer (Revenue) Market Share in 2019 Figure 35. Top 6 Axial Spondyloarthritis Drugs Manufacturer (Revenue) Market Share in 2019 Figure 36. Key Manufacturer Market Share Trend Figure 37. Global Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 38. Global Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 39. Global Axial Spondyloarthritis Drugs Revenue Market Share by Regions (2015-2020) Figure 40. Global Axial Spondyloarthritis Drugs Revenue Market Share by Regions in 2018 Figure 41. North America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) Figure 42. Europe Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) Figure 43. Asia-Pacific Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) Figure 44. South America Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) Figure 45. Middle East & Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) Figure 46. North America Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 47. North America Axial Spondyloarthritis Drugs Sales Market Share by Countries (2015-2020) Figure 48. North America Axial Spondyloarthritis Drugs Sales Market Share by Countries in 2018 Figure 49. North America Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020) (USD Million) Figure 50. North America Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2018 Figure 51. United States Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 52. Canada Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 53. Mexico Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 54. Europe Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 55. Europe Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020) Figure 56. Europe Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2019 Figure 57. Germany Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 58. UK Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 59. France Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 60. Russia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 61. Italy Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 62. Asia-Pacific Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 63. Asia-Pacific Axial Spondyloarthritis Drugs Sales Market Share by Regions 2019 Figure 64. Asia-Pacific Axial Spondyloarthritis Drugs Revenue Market Share by Regions 2019 Figure 65. China Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 66. Japan Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 67. Korea Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 68. India Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 69. Southeast Asia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 70. South America Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 71. South America Axial Spondyloarthritis Drugs Sales Market Share by Countries in 2019 Figure 72. South America Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2019 Figure 73. Brazil Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 74. Argentina Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 75. Middle East and Africa Axial Spondyloarthritis Drugs Revenue and Growth Rate (2015-2020) (USD Million) Figure 76. Middle East and Africa Axial Spondyloarthritis Drugs Sales Market Share by Countries in 2019 Figure 77. Middle East and Africa Axial Spondyloarthritis Drugs Revenue Market Share by Countries (2015-2020) Figure 78. Middle East and Africa Axial Spondyloarthritis Drugs Revenue Market Share by Countries in 2019 Figure 79. Saudi Arabia Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 80. Egypt Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 81. Turkey Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 82. South Africa Axial Spondyloarthritis Drugs Sales and Growth Rate (2015-2020) (K Pcs) Figure 83. Global Axial Spondyloarthritis Drugs Sales and Growth Rate (2021-2025) (K Pcs) Figure 84. Global Axial Spondyloarthritis Drugs Revenue and Growth Rate (2021-2025) (USD Million) Figure 85. North America Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs) Figure 86. Europe Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs) Figure 87. Asia-Pacific Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs) Figure 88. South America Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs) Figure 89. Middle East & Africa Sales Axial Spondyloarthritis Drugs Market Forecast (2021-2025) (K Pcs) Figure 90. Sales Channel: Direct Channel vs Indirect Channel

AstraZeneca Plc UCB SA Novartis AG Eli Lilly and Company Sun Pharma Advanced Research Company Ltd Johnson & Johnson Sandoz International GmbH Panacea Biotec Ltd